Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 05, 2020 10:44 ET | Source: Nascent Biotech, Inc.

Nascent Biotech, Inc. CEO Interviewed by The Wall Street Analyzer

San Diego, CA, Feb. 05, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB: NBIO) is pleased to release a recent interview with company President | CEO Sean Carrick, on The...
January 30, 2020 10:00 ET | Source: Nascent Biotech, Inc.

Nascent Biotech Founder, Dr. Mark Glassy, Will Present at the Clinical Operation in Oncology Trials Meeting, in San Diego in February

SAN DIEGO, CA , Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nascent Biotech, Inc. (OTCQB: NBIO) founder Dr. Mark C. Glassy will be presenting on “Navigating the Unique Challenges Presented...
January 15, 2020 10:04 ET | Source: Nascent Biotech, Inc.

Nascent Biotech, Inc. Featured in New Research Update

San Diego, CA, Jan. 15, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB: NBIO), an emerging biotech company, with IND Clearance and IRB approval to begin Clinical trials...
September 11, 2019 08:30 ET | Source: Nascent Biotech, Inc.

Nascent Biotech Receives One Million Dollar Commitment From TRITON FUNDS LP

SAN DIEGO, Calif., Sept. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB:NBIO), a biopharmaceutical company focusing on the development of monoclonal antibodies for the...
August 19, 2019 14:04 ET | Source: Nascent Biotech, Inc.

Nascent Biotech Has Entered into an Agreement to Perform Phase I Clinical Study for Brain Cancer

Study Planned for Multiple Brain Cancer Types in Phase I Setting San Diego, CA, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB: NBIO), today announced they...
June 05, 2019 09:00 ET | Source: Nascent Biotech, Inc.

Nascent Biotech Officers Convert Liability to Stock in the Company

San Diego, CA, June 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTC: NBIO) announced today that two of its Senior Officers have converted the Company’s liability to them...
May 09, 2019 08:30 ET | Source: Nascent Biotech, Inc.

Nascent Biotech Founder, Dr. Mark Glassy, Will Present at AAI Convention in San Diego

SAN DIEGO, CA, May 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB: NBIO) founder Dr. Mark C. Glassy will present an abstract on a natural human lgG1 mAb, Pritumumab,...
April 09, 2019 12:53 ET | Source: Nascent Biotech, Inc.

Nascent Biotech Moves Corporate Offices to San Diego

San Diego, CA, April 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB: NBIO) has moved their corporate offices to San Diego, CA. Nascent CEO Sean Carrick stated,...
December 11, 2018 08:00 ET | Source: Nascent Biotech, Inc.

Nascent Biotech Receives Clearance From FDA to Begin Phase I Human Trials in Brain Cancer

Vero Beach, FL, Dec. 11, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTC: NBIO) received US Food and Drug Administration (FDA) Clearance to begin Phase 1 Clinical Trials...